US Stock MarketDetailed Quotes

ARQT Arcutis Biotherapeutics

Watchlist

12.780
+0.470+3.82%

Close Feb 14 16:00 ET

12.869
+0.089+0.69%

Post 19:36 ET

1.50BMarket Cap-7.65P/E (TTM)

Arcutis Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Arcutis Biotherapeutics Q4 2024 Estimates Date

Currency：USDFeb 25, 2025

	Estimate	YoY
Revenue	60.52M	+347.41%
EPS	-0.24	+66.22%

Analyst Rating

Strong Buy

Feb 16, 2025

Arcutis Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 63.192M	--
Feb 25, 2025	2024/Q4	-- / 60.517M	--
Nov 6, 2024	2024/Q3	44.755M / 37.340M	--
Aug 14, 2024	2024/Q2	30.858M / 29.080M	--
May 14, 2024	2024/Q1	49.569M / 15.140M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 63.192M--

Feb 25, 20252024/Q4-- / 60.517M--

Nov 6, 20242024/Q344.755M / 37.340M--

Aug 14, 20242024/Q230.858M / 29.080M--

May 14, 20242024/Q149.569M / 15.140M--

Unlock Free Earnings Estimates

Open Account

Arcutis Biotherapeutics Earnings Reports

Arcutis Biotherapeutics | 10-Q: Q3 2024 Earnings Report

Nov 6, 2024 16:12 ET

Arcutis Biotherapeutics | 8-K: Arcutis Announces Third Quarter 2024 Financial Results and Provides Business Update

Nov 6, 2024 16:07 ET

Arcutis Biotherapeutics | 10-Q: Q2 2024 Earnings Report

Aug 14, 2024 16:18 ET

Arcutis Biotherapeutics | 8-K: Arcutis Announces Second Quarter 2024 Financial Results and Provides Business Update

Aug 14, 2024 16:06 ET